Literature DB >> 17088357

Cellular recognition of Mycobacterium tuberculosis ESAT-6 and KatG peptides in systemic sarcoidosis.

Wonder P Drake1, Mary S Dhason, Michele Nadaf, Bryan E Shepherd, Sangeetha Vadivelu, Rana Hajizadeh, Lee S Newman, Spyros A Kalams.   

Abstract

Sarcoidosis is an enigmatic disease with a pathology similar to that of tuberculosis. We detected Th-1 immune responses to Mycobacterium tuberculosis ESAT-6 and KatG peptides from peripheral blood mononuclear cells from 15/26 sarcoidosis, 1/24 purified-protein-derivative-negative (PPD-) (P < 0.0001, Fisher's exact test), and 7/8 PPD-positive (PPD+) subjects (P = 0.21). This finding provides immunologic links between mycobacteria and systemic sarcoidosis.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17088357      PMCID： PMC1828402          DOI： 10.1128/IAI.00732-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  15 in total

1.  Mycobacterium tuberculosis complex and mycobacterial heat shock proteins in lymph node tissue from patients with pulmonary sarcoidosis.

Authors:  Anna Dubaniewicz; Miroslawa Dubaniewicz-Wybieralska; Adam Sternau; Zofia Zwolska; Ewa Izycka-Swieszewska; Ewa Augustynowicz-Kopec; Jaroslaw Skokowski; Mahavir Singh; Lech Zimnoch
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

Review 2.  Sarcoidosis.

Authors:  L S Newman; C S Rose; L A Maier
Journal:  N Engl J Med       Date:  1997-04-24       Impact factor: 91.245

3.  An inhibitor of the toxicity of tumour necrosis factor in the serum of patients with sarcoidosis, tuberculosis and Crohn's disease.

Authors:  N Foley; C Lambert; M McNicol; N Johnson; G A Rook
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

4.  High frequencies of circulating IFN-gamma-secreting CD8 cytotoxic T cells specific for a novel MHC class I-restricted Mycobacterium tuberculosis epitope in M. tuberculosis-infected subjects without disease.

Authors:  A A Pathan; K A Wilkinson; R J Wilkinson; M Latif; H McShane; G Pasvol; A V Hill; A Lalvani
Journal:  Eur J Immunol       Date:  2000-09       Impact factor: 5.532

5.  Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment.

Authors:  A A Pathan; K A Wilkinson; P Klenerman; H McShane; R N Davidson; G Pasvol; A V Hill; A Lalvani
Journal:  J Immunol       Date:  2001-11-01       Impact factor: 5.422

6.  Sarcoidosis: histopathological definition and clinical diagnosis.

Authors:  D N Mitchell; J G Scadding; B E Heard; K F Hinson
Journal:  J Clin Pathol       Date:  1977-05       Impact factor: 3.411

7.  Characterization of the katG gene encoding a catalase-peroxidase required for the isoniazid susceptibility of Mycobacterium tuberculosis.

Authors:  B Heym; Y Zhang; S Poulet; D Young; S T Cole
Journal:  J Bacteriol       Date:  1993-07       Impact factor: 3.490

8.  Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis.

Authors:  B W Robinson; T L McLemore; R G Crystal
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

9.  Spontaneous release of interleukin 2 by lung T lymphocytes in active pulmonary sarcoidosis is primarily from the Leu3+DR+ T cell subset.

Authors:  C Saltini; J R Spurzem; J J Lee; P Pinkston; R G Crystal
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

10.  Molecular analysis of sarcoidosis tissues for mycobacterium species DNA.

Authors:  Wonder Puryear Drake; Zhiheng Pei; David T Pride; Robert D Collins; Timothy L Cover; Martin J Blaser
Journal:  Emerg Infect Dis       Date:  2002-11       Impact factor: 6.883
View more
  59 in total

1.  Enzyme-linked immunospot assay (ELISPOT): Quantification of Th-1 cellular immune responses against microbial antigens.

Authors:  Isfahan R Chambers; Tiffany R Cone; Kyra Oswald-Richter; Wonder P Drake
Journal:  J Vis Exp       Date:  2010-11-23       Impact factor: 1.355

Review 2.  A concise review of pulmonary sarcoidosis.

Authors:  Robert P Baughman; Daniel A Culver; Marc A Judson
Journal:  Am J Respir Crit Care Med       Date:  2010-10-29       Impact factor: 21.405

Review 3.  Sarcoidosis--scientific progress and clinical challenges.

Authors:  Edward S Chen; David R Moller
Journal:  Nat Rev Rheumatol       Date:  2011-07-12       Impact factor: 20.543

4.  T cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis.

Authors:  Edward S Chen; Jan Wahlström; Zhimin Song; Matthew H Willett; Maria Wikén; Rex C Yung; Erin E West; John F McDyer; Ying Zhang; Anders Eklund; Johan Grunewald; David R Moller
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

5.  Infectious antigens may play a role in the pathogenesis of sarcoidosis.

Authors:  Wonder Drake
Journal:  Medscape J Med       Date:  2008-12-22

6.  Linkage between Toll-like receptor (TLR) 2 promotor and intron polymorphisms: functional effects and relevance to sarcoidosis.

Authors:  M Veltkamp; P A H M Wijnen; C H M van Moorsel; G T Rijkers; H J T Ruven; M Heron; O Bekers; A M E Claessen; M Drent; J M M van den Bosch; J C Grutters
Journal:  Clin Exp Immunol       Date:  2007-06-12       Impact factor: 4.330

7.  Development of a sarcoidosis murine lung granuloma model using Mycobacterium superoxide dismutase A peptide.

Authors:  Carmen M Swaisgood; Kyra Oswald-Richter; Stephen D Moeller; Jennifer M Klemenc; Lisa M Ruple; Carol F Farver; John M Drake; Daniel A Culver; Wonder P Drake
Journal:  Am J Respir Cell Mol Biol       Date:  2010-03-26       Impact factor: 6.914

Review 8.  Evidence for mycobacteria in sarcoidosis.

Authors:  Isaac Brownell; Francisco Ramírez-Valle; Miguel Sanchez; Stephen Prystowsky
Journal:  Am J Respir Cell Mol Biol       Date:  2011-06-09       Impact factor: 6.914

9.  Peroxisome Proliferator-activated Receptor-γ Deficiency Exacerbates Fibrotic Response to Mycobacteria Peptide in Murine Sarcoidosis Model.

Authors:  Anagha Malur; Arjun Mohan; Robert A Barrington; Nancy Leffler; Amrita Malur; Barbara Muller-Borer; Gina Murray; Kim Kew; Chuanzhen Zhou; Josh Russell; Jacob L Jones; Christopher J Wingard; Barbara P Barna; Mary Jane Thomassen
Journal:  Am J Respir Cell Mol Biol       Date:  2019-08       Impact factor: 6.914

10.  Effects of broad-spectrum antimycobacterial therapy on chronic pulmonary sarcoidosis.

Authors:  W P Drake; B W Richmond; K Oswald-Richter; C Yu; J M Isom; J A Worrell; G R Shipley
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2013-11-25       Impact factor: 0.670
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.